Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional

Efficacy of SUN N4057 in Subjects With Acute Ischemic Stroke and Measurable Penumbra on Magnetic Resonance Imaging (MRI)

ClinicalTrials.gov ID: NCT00272909

Public ClinicalTrials.gov record NCT00272909. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 18, 2026, 3:36 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase IIb Randomized, Double-blind, Placebo-Controlled, Group-Sequential, Multicenter, Dose Finding Study of the Safety and Efficacy of SUN N4057 (Piclozotan) Administered for 72 Hours by Continuous Intravenous Infusion in Subjects With Acute Ischemic Stroke and Measurable Penumbra on MRI

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This research study is designed to evaluate the safety, tolerability, and efficacy of SUN N4057 (piclozotan) in subjects with acute ischemic stroke within 9 hours of the onset of symptoms.

Study identification

NCT ID
NCT00272909
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Daiichi Sankyo
Industry
Enrollment
43 participants

Conditions and interventions

Conditions

Eligibility (public fields only)

Age range
18 Years to 85 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 2004 (Type not available)
Primary completion
Oct 2006 (Actual)
Completion
Jan 2007 (Actual)
Last update posted
Oct 20, 2015

2004 – 2007

United States locations

U.S. sites
25
U.S. states
20
U.S. cities
25
Facility City State ZIP Site status
UCLA Stroke Network Los Angeles California 90024 —
San Francisco Clinical Research Center San Francisco California 94109 —
The Stroke Center at Hartford Hospital Hartford Connecticut 06102 —
Lakeland Regional Medical Center Lakeland Florida 33805 —
OCALA Neurodiagnostic Center Ocala Florida 34471 —
Southern Illinois University School of Medicine Springfield Illinois 62702 —
Ruan Neurology Clinic and Clinical Research Center Des Moines Iowa 50314 —
Via Christi Regional Medical Center Wichita Kansas 67214 —
University of Kentucky, Sanders Brown Center on Aging/Stroke Program Lexington Kentucky 40536 —
University of Massachusetts, Memorial Health Center, Department of Neurology Worcester Massachusetts 01655 —
Wayne State University Detroit Michigan 48201 —
Michigan State University, Sparrow Health System East Lansing Michigan 48824 —
St. Luke's Hospital Kansas City Missouri 64111 —
Advance Neurology Specialists Great Falls Montana 59405 —
St. Francis Medical Center Trenton New Jersey 08629 —
SUNY at Stony Brook, University Hospital at Stony Brook Stony Brook New York 11794 —
Moses Cone Hospital Greensboro North Carolina 27401 —
Clinical Research Center of Winston-Salem Winston-Salem North Carolina 27103 —
Summa Health System Neurology and Neuroscience Associates Akron Ohio 44309 —
Chattanooga Neurology Associates Chattanooga Tennessee 37404 —
Methodist University Hospital Memphis Tennessee 38104 —
The Methodist Hospital Neurological Institute Houston Texas 77030 —
INOVA Research Center Falls Church Virginia 22042 —
Charleston Area Medical Center Health Education and Research Institute Charleston West Virginia 25304 —
Medical College of Wisconsin Milwaukee Wisconsin 53226 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 22 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00272909, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 20, 2015 · Synced Oct 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00272909 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →